{
    "2018-03-27": [
        [
            {
                "time": "2018-03-27",
                "original_text": "研报精选：6股值得关注（3.27）",
                "features": {
                    "keywords": [
                        "云计算",
                        "产业",
                        "发展拐点",
                        "潜力公司"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "云计算"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-26",
                "original_text": "[买入评级] 医药生物行业投资策略：部委调整 明确医保医疗医药三方职责",
                "features": {
                    "keywords": [
                        "医药生物",
                        "部委调整",
                        "医保",
                        "医疗",
                        "医药"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-26",
                "original_text": "[中性评级] 华兰生物（002007）年报点评：营销改革持续推进 收入端有所改善",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "营销改革",
                        "收入改善"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-26",
                "original_text": "【医药-华兰生物（002007）】江琦、赵磊（联系人）：2017年报点评：血制品销售稳定，关注后续四价流感疫苗-20180326",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "血制品",
                        "四价流感疫苗"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-26",
                "original_text": "长生生物业绩稳增 布局生物医药",
                "features": {
                    "keywords": [
                        "长生生物",
                        "业绩增长",
                        "生物医药"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-26",
                "original_text": "华兰生物:业绩环比改善明显,新品研发衔枚疾进",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "业绩改善",
                        "新品研发"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-26",
                "original_text": "华兰生物:血制品业务恢复,费用有所上升",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "血制品",
                        "费用上升"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-26",
                "original_text": "[增持-A评级] 华兰生物（002007）年报点评：行业筑底中 仍看好公司中长期成长空间",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "行业筑底",
                        "中长期成长"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-26",
                "original_text": "华兰生物：血制品营销改革持续推进 推荐评级",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "营销改革",
                        "推荐评级"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-26",
                "original_text": "中泰证券：全视角个股",
                "features": {
                    "keywords": [
                        "中泰证券",
                        "全视角",
                        "个股"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}